FDAsafety guidance66% confidence
FDA AP — TRAMADOL HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Bupropion Hydrochloride; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA075968. Sponsor: GRAVITI PHARMS. Submission status: AP. Submission type: SUPPL. Active ingredients: TRAMADOL HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Mental Health · Antidepressant
- Sub-indication
- General
Related signal: FDA Grants Abbreviated Approval for Bupropion Hydrochloride by Graviti Pharms